10.6084/m9.figshare.12602219.v1 Mourad F. Rezk Mourad F. Rezk Burkhard Pieper Burkhard Pieper Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Disease: A Narrative Review Adis Journals 2020 Access to treatment Anti-TNF Biosimilars Disease burden Early treatment IMIDs Maintenance of remission Patient outcomes Rheumatology 2020-07-14 14:53:56 Media https://adisjournals.figshare.com/articles/media/Unlocking_the_Value_of_Anti-TNF_Biosimilars_Reducing_Disease_Burden_and_Improving_Outcomes_in_Chronic_Immune-Mediated_Inflammatory_Disease_A_Narrative_Review/12602219 <p><strong>Article full text</strong></p> <p><br></p> <p><br> The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). </p> <p>© The authors, CC-BY-NC 2020.<b> </b></p>